A.L.S. Drug Relyvrio Will Be Taken Off the Market, Its Maker Saysnews2024-04-04T12:18:29+00:00April 4th, 2024|The New York Times|
El caso sobre las píldoras abortivas en la Corte Suprema en 4 conclusionesnews2024-03-28T17:14:13+00:00March 28th, 2024|The New York Times|
Supreme Court Seems Inclined to Reject Bid to Curtail Abortion Pill Accessnews2024-03-27T00:24:42+00:00March 27th, 2024|The New York Times|
Key Takeaways From Supreme Court Arguments on Abortion Pill Accessnews2024-03-26T19:53:14+00:00March 26th, 2024|The New York Times|
What Is Mifepristone and How Is It Used?news2024-03-26T12:53:35+00:00March 26th, 2024|The New York Times|
Lo que hay que saber sobre la ibogaínanews2024-03-09T10:02:51+00:00March 9th, 2024|The New York Times|
A.L.S. Drug Relyvrio Fails Clinical Trial and May Be Withdrawn From the Marketnews2024-03-08T15:06:16+00:00March 8th, 2024|The New York Times|
F.D.A. Delays Action on Closely Watched Alzheimer’s Drugnews2024-03-08T11:45:07+00:00March 8th, 2024|The New York Times|
Powerful Psychedelic Drug Gains New Notice as an Opioid Addiction Therapynews2024-03-05T18:32:51+00:00March 5th, 2024|The New York Times|
What to Know About Ibogaine, a Psychedelicnews2024-03-05T08:00:07+00:00March 5th, 2024|The New York Times|
